| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6095698 | Gastroenterology | 2011 | 13 Pages |
Abstract
DARPP-32 promotes resistance of gastric cancer cells to gefitinib by promoting interaction between EGFR and ERBB3 and activating phosphatidylinositol-3-kinase-AKT signaling.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Shoumin Zhu, Abbes Belkhiri, Wael El-Rifai,